Echinacea: Clinical Trials

7 trials of Echinacea, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

7 completed. 3 Phase 4, 2 Phase 3, 1 Not applicable, 1 Phase 2.

By phase and status

PhaseTrialsStatus
Phase 43Completed 3
Phase 32Completed 2
Not applicable1Completed 1
Phase 21Completed 1

Follow Echinacea: new trials by email Literature Review of Echinacea trials Research Report on Echinacea

Trials newest first · largest first

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Echinaforce Study to Investigate Explorative Pharmacology and Effectiveness to Prevent From Enveloped Virus Infections
Echinaforce Chewable tablets - Respiratory Tract Infections, Common Cold
Phase 4CompletedA. Vogel AG1222020-11-202021-08-12
Impact of Echinacea as Prophilaxis for Upper Respiratory Tract Infections in Children 1-5 Years
Echinacea, Placebo - Upper Respiratory Tract Infections
Not applicableCompletedHormozgan University of Medical Sciences1002010-05-012011-07-22
Drug Interactions Between Echinacea Purpurea and Darunavir/Ritonavir
Echinacea - HIV Infections
Phase 4CompletedGermans Trias i Pujol Hospital152010-01-012019-12-04
Echinacea Safety Study
echinacea, placebo - Infections
Phase 4CompletedA. Vogel AG7572009-10-012014-07-23
Echinacea Versus Placebo Effect in Common Cold (Physician Echinacea Placebo)
Echinacea, Blinded placebo - Common Cold
Phase 3CompletedUniversity of Wisconsin, Madison7192003-09-012014-12-04
Evaluation of Echinacea for the Common Cold
Echinacea - Common Cold
Phase 2CompletedNational Center for Complementary and Integrative Health (NCCIH)2001-09-012006-08-18
A Trial of Echinacea in Children
Echinacea - Common Cold
Phase 3CompletedNational Center for Complementary and Integrative Health (NCCIH)6002000-04-012006-08-18

Conditions studied

Common Cold (4)  ·  Respiratory Tract Infections (2)  ·  HIV Infections (1)  ·  Infections (1)  ·  Virus Diseases (1)

Sponsors

A. Vogel AG (2)  ·  National Center for Complementary and Integrative Health (NCCIH) (2)  ·  Germans Trias i Pujol Hospital (1)  ·  Hormozgan University of Medical Sciences (1)  ·  University of Wisconsin, Madison (1)

Countries

United States (3)  ·  Bulgaria (1)  ·  Iran (1)  ·  Spain (1)  ·  United Kingdom (1)

Top investigators

Bruce Barrett, MD PhD (1)  ·  Emil Kolev, Dr. med. (1)  ·  J. David Gangemi, PhD (1)  ·  James Taylor, MD (1)  ·  Ronald B. Turner, MD (1)  ·  Roya Firoozi, Resident (1)  ·  Rudolf Bauer, PhD (1)

Results publications

PMID 16049208, PMID 21173411, PMID 22046723

NIH funding

R01AT001428 (1)